The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease (Q69869855)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

1 reference

6

S Targan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

M Brogan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J Hiserodt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M Oliver

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

R Stevens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

B Korelitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 May 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

204-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3874211%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00915512

6 October 2019

exact match

0 references

cites work

Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients

1 reference

12 December 2020

Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease

1 reference

12 December 2020

Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria

1 reference

12 December 2020

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

1 reference

12 December 2020

Cytotoxicity of mononuclear cells for autologous colonic epithelial cells in colonic diseases

1 reference

12 December 2020

NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells

1 reference

12 December 2020

Natural killer activity of gut mucosal lymphoid cells in mice

1 reference

12 December 2020

Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect

1 reference

12 December 2020

Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine

1 reference

12 December 2020

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

1 reference

12 December 2020

Controlled trial of azathioprine in Crohn's disease

1 reference

12 December 2020

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

12 December 2020

Comparison of the effector cells in human spontaneous cellular cytotoxicity and antibody-dependent cellular cytotoxicity: differential sensitivity of effector cells to in vivo and in vitro corticosteroids

1 reference

12 December 2020

Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: results of drug treatment

1 reference

12 December 2020

Appearance of killer (K) cells in the mesenteric lymph nodes in Crohn's disease

1 reference

12 December 2020

Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood

1 reference

12 December 2020

Isolation of spontaneous and interferon inducible natural killer like cells from human colonic mucosa: lysis of lymphoid and autologous epithelial target cells.

1 reference

12 December 2020

Locus of selective depression of human natural killer cells by azathioprine

1 reference

12 December 2020

Immunoperoxidase localization of large granular lymphocytes in normal tissues and lesions of athymic nude rats

1 reference

12 December 2020

A controlled trial of azathioprine in Crohn's disease

1 reference

12 December 2020

Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization

1 reference

12 December 2020

Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis

1 reference

12 December 2020